This review summarizes the literature on the impact of MYC rearrangement, as well as MYC/BCL2 double hit, in patients with DLBCL and BCL-U.     ///    "These subsets have been associated with a poor patient outcome, with the data being strongest for MYC/BCL2 double hit lymphomas. "